Literature DB >> 1145192

Chronotypic action of theophylline and of pentobarbital as circadian zeitgebers in the rat.

C F Ehret, V R Potter, K W Dobra.   

Abstract

In the rat the deep body temperature rhythm, monitored by telemetry, can be reset in a predictable direction by a stimulant (theopylline) and by a depressant (pentobarbital). When the drugs are applied immediately before or during the early active phases of the circadian cycle, the rhythm is set back (phase delay). When applied later, past the thermal peak, theophylline, but not pentobarbital, shifts the rhythm ahead (phase advance). Theophylline and pentobarbital in addition to having a number of already established pharmacological properties are now further identified as chronobiotics: they are drugs that may be used to alter the biological time structure by rephasing a circadian rhythm.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1145192     DOI: 10.1126/science.1145192

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Timing of single daily meal influences relations among human circadian rhythms in urinary cyclic AMP and hemic glucagon, insulin and iron.

Authors:  F Goetz; J Bishop; F Halberg; R B Sothern; R Brunning; B Senske; B Greenberg; D Minors; P Stoney; I D Smith; G D Rosen; D Cressey; E Haus; M Apfelbaum
Journal:  Experientia       Date:  1976-08-15

2.  Effects of cAMP, theophylline, imidazole, and 4-(3,4-dimethoxybenzyl)-2-imidazolidone on the leaf movement rhythm of Trifolium repens-a test of the cAMP-hypothesis of circadian rhythms.

Authors:  I Bollig; K Mayer; W E Mayer; W Engelmann
Journal:  Planta       Date:  1978-01       Impact factor: 4.116

Review 3.  Time -- a key in experimental and practical medicine.

Authors:  H Mayersbach
Journal:  Arch Toxicol       Date:  1976-12-17       Impact factor: 5.153

Review 4.  Approaches to the Pharmacological Management of Jet Lag.

Authors:  Josephine Arendt
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.